AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26

Authors: KOITER J NAVIS G DEJONG PE VANGILST WH DEZEEUW D
Citation: J. Koiter et al., SAMPLE DILUTION - A METHODOLOGICAL PITFALL IN THE MEASUREMENT OF TISSUE BUT NOT SERUM ACE-ACTIVITY, Journal of pharmacological and toxicological methods, 39(1), 1998, pp. 45-49

Authors: HOOGENBERG K SLUITER WJ NAVIS G VANHAEFTEN TW SMIT AJ REITSMA WD DULLAART RPF
Citation: K. Hoogenberg et al., EXOGENOUS NOREPINEPHRINE INDUCES AN ENHANCED MICROPROTEINURIC RESPONSE IN MICROALBUMINURIC INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of the American Society of Nephrology, 9(4), 1998, pp. 643-654

Authors: BROEKROELOFS J STEGEMAN CA NAVIS G TEGZESS AM DEZEEUW D DEJONG PE
Citation: J. Broekroelofs et al., RISK-FACTORS FOR LONG-TERM RENAL SURVIVAL AFTER RENAL-TRANSPLANTATION- A ROLE FOR ANGIOTENSIN-CONVERTING ENZYME (INSERTION DELETION) POLYMORPHISM/, Journal of the American Society of Nephrology, 9(11), 1998, pp. 2075-2081

Authors: BUTER H HEMMELDER MH NAVIS G DEJONG PE DEZEEUW D
Citation: H. Buter et al., THE BLUNTING OF THE ANTIPROTEINURIC EFFICACY OF ACE-INHIBITION BY HIGH SODIUM-INTAKE CAN BE RESTORED BY HYDROCHLOROTHIAZIDE, Nephrology, dialysis, transplantation, 13(7), 1998, pp. 1682-1685

Authors: HOOGENBERG K NAVIS G DULLAART RPF
Citation: K. Hoogenberg et al., NOREPINEPHRINE-INDUCED BLOOD-PRESSURE RISE AND RENAL VASOCONSTRICTIONARE NOT ATTENUATED BY ENALAPRIL TREATMENT IN MICROALBUMINURIC IDDM, Nephrology, dialysis, transplantation, 13(3), 1998, pp. 640-645

Authors: DEVRIES PAM NAVIS G DEJONG PE DEZEEUW D
Citation: Pam. Devries et al., CAN CONTINUOUS INTRAPERITONEAL INFUSION OF I-125 IOTHALAMATE AND I-131 HIPPURAN BE USED FOR MEASUREMENT OF GFR IN CONSCIOUS RATS, Renal failure, 20(2), 1998, pp. 249-255

Authors: BROEKROELOFS J STEGEMAN CA VANDERBIJ W DEJONG PE NAVIS G
Citation: J. Broekroelofs et al., RENAL-FAILURE AFTER LUNG TRANSPLANTATION - REPLY, Lancet, 352(9121), 1998, pp. 69-70

Authors: BROEKROELOFS J NAVIS G STEGEMAN CA VANDERBIJ W DEJONG PE
Citation: J. Broekroelofs et al., LUNG TRANSPLANTATION, Lancet, 351(9108), 1998, pp. 1064-1064

Authors: LOEF BG HENNING RH NAVIS G VONOEVEREN W EPEMA AH
Citation: Bg. Loef et al., BEATING HEART CORONARY-ARTERY SURGERY AVOIDS RENAL DAMAGE AS COMPAREDTO SURGERY WITH CARDIOPULMONARY BYPASS, Anesthesiology, 89(3A), 1998, pp. 297-297

Authors: BUTER H NAVIS G DEZEEUW D DEJONG PE
Citation: H. Buter et al., RENAL HEMODYNAMIC-EFFECTS OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST CANDESARTAN CILEXITIL IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION, Journal of the American Society of Nephrology, 8, 1997, pp. 1586-1586

Authors: DEBOER E NAVIS G TIEBOSCH ATMG DEJONG PE DEZEEUW D
Citation: E. Deboer et al., SYSTEMIC FACTORS ARE INVOLVED IN PROTEINURIA-INDUCED RENAL DAMAGE, Journal of the American Society of Nephrology, 8, 1997, pp. 2857-2857

Authors: NAVIS G DEJONG PE DEZEEUW D
Citation: G. Navis et al., I D POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME GENE - A CLUE TO THE HETEROGENEITY IN THE PROGRESSION OF RENAL-DISEASE AND IN THE RENAL RESPONSE TO THERAPY/, Nephrology, dialysis, transplantation, 12(6), 1997, pp. 1097-1100

Authors: BUTER H HEMMELDER MH VANPAASSEN P NAVIS G DEZEEUW D DEJONG PE
Citation: H. Buter et al., IS THE ANTIPROTEINURIC RESPONSE TO INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM LESS EFFECTIVE DURING THE NIGHT, Nephrology, dialysis, transplantation, 12, 1997, pp. 53-56

Authors: NAVIS G VANDERKLEIJ F SCHMIDT A HAAS M YILMAZ N DEJONG P DEZEEUW D MAYER G
Citation: G. Navis et al., GENETIC-DETERMINANTS OF PROGRESSIVE RENAL-DISEASE - IMPACT ON THERAPEUTIC INTERVENTIONS IN NONDIABETIC RENAL-DISEASE, Hypertension, 30(4), 1997, pp. 63-63

Authors: NAVIS G DEZEEUW D DEJONG PE
Citation: G. Navis et al., ACE-INHIBITORS - PANACEA FOR PROGRESSIVE RENAL-DISEASE, Lancet, 349(9069), 1997, pp. 1852-1853

Authors: BUTER H NAVIS G DEZEEUW D DEJONG PE
Citation: H. Buter et al., RENAL HEMODYNAMIC-EFFECTS OF CANDESARTAN IN NORMAL AND IMPAIRED RENAL-FUNCTION IN HUMANS, Kidney international, 1997, pp. 185-187

Authors: BUTER H NAVIS G DEZEEUW D DEJONG PE
Citation: H. Buter et al., RENAL HEMODYNAMIC-EFFECTS OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST CANDESARTAN IN PATIENTS WITH IMPAIRED AND NORMAL RENAL-FUNCTION, Kidney international, 52(2), 1997, pp. 575-576

Authors: DEVRIES PAM NAVIS G DEBOER E DEJONG PE DEZEEUW D KLUPPEL CA
Citation: Pam. Devries et al., A METHOD FOR ACCURATE MEASUREMENT OF GFR IN CONSCIOUS, SPONTANEOUSLY VOIDING RATS, Kidney international, 52(1), 1997, pp. 244-247

Authors: BUTER H HEMMELDER MH VANPAASSEN P NAVIS G DEZEEUW D DEJONG PE
Citation: H. Buter et al., IS THE ANTIPROTEINURIC RESPONSE OF INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM (RAS) SIMILAR DURING NIGHT AND DAY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 420-420

Authors: WAPSTRA FH NAVIS G DEJONG PE DEZEEUW D
Citation: Fh. Wapstra et al., PROGNOSTIC VALUE OF THE SHORT-TERM ANTIPROTEINURIC RESPONSE TO ACE-INHIBITION FOR PREDICTION OF GFR DECLINE IN PATIENTS WITH NONDIABETIC RENAL-DISEASE, Experimental nephrology, 4, 1996, pp. 47-52

Authors: NAVIS G DEZEEUW D
Citation: G. Navis et D. Dezeeuw, TITRATING FOR ANTIPROTEINURIC EFFECT - THE CLUE TO RENOPROTECTION, Journal of human hypertension, 10(10), 1996, pp. 669-673

Authors: VISSCHER CA DEZEEUW D NAVIS G VANZANTEN AK DEJONG PE HUISMAN RM
Citation: Ca. Visscher et al., RENAL I-131 HIPPURATE CLEARANCE OVERESTIMATES TRUE RENAL BLOOD-FLOW IN THE INSTRUMENTED CONSCIOUS DOG, American journal of physiology. Renal, fluid and electrolyte physiology, 40(2), 1996, pp. 269-274

Authors: VANPAASSEN P DEZEEUW D NAVIS G DEJONG PE
Citation: P. Vanpaassen et al., DOES THE RENIN-ANGIOTENSIN SYSTEM DETERMINE THE RENAL AND SYSTEMIC HEMODYNAMIC-RESPONSE TO SODIUM IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Hypertension, 27(2), 1996, pp. 202-208

Authors: WAPSTRA FH VANGOOR H NAVIS G DEJONG PE DEZEEUW D
Citation: Fh. Wapstra et al., ANTIPROTEINURIC EFFECT PREDICTS RENAL PROTECTION BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN RATS WITH ESTABLISHED ADRIAMYCIN NEPHROSIS, Clinical science, 90(5), 1996, pp. 393-401

Authors: NAVIS G FABER HJ DEZEEUW D DEJONG PE
Citation: G. Navis et al., ACE-INHIBITORS AND THE KIDNEY - A RISK-BENEFIT ASSESSMENT, Drug safety, 15(3), 1996, pp. 200-211
Risultati: 1-25 | 26-26